Atlas Trials

Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure

Clinical trial NCT01346215 · UNKNOWN

Trial details

NCT number
NCT01346215
Sponsor
Laboratório Químico Farmacêutico Bergamo Ltda.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Renal Failure
Start date
2011-10-01
Primary completion
2011-12-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.